GlobeNewswire Inc.··Researchandmarkets.ComGLP-1 Market Set to Nearly Triple to $137B by 2030 as Drug Class Expands Beyond Diabetes
GLP-1 receptor agonist market projected to surge from $51.9B in 2024 to $137.4B by 2030, driven by obesity prevalence and expanded therapeutic applications.
AMGNPFELLYNVORHHBY+1weight lossdiabetes treatment